
Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer
Author(s) -
Gamze Aköz,
Gülden Diniz,
Sümeyye Ekmekçi,
Rahmi Gökhan Ekin,
Melek Ünçel
Publication year - 2018
Publication title -
indian journal of pathology and microbiology/indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/ijpm.ijpm_465_17
Subject(s) - epidermal growth factor receptor , human epidermal growth factor receptor 2 , triple negative breast cancer , cancer , cancer research , epidermal growth factor , breast cancer , human breast , receptor , biology , immunohistochemistry , medicine , endocrinology
Human epididymal secretory protein 4 (HE4) is originally described as an epididymis-specific protein but more recently suggested to be a putative serum tumor marker for some tumors, including breast carcinomas. In this study, we aimed to investigate the interactions between HE4 expression and molecular subtypes of breast carcinomas.